PBM · Psyence Biomedical Ltd
United States · RS rating 28 · As of 2026-11-03
| Price | 3.29 USD |
|---|---|
| 1-day change | +3.5% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 9 / 66 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 15 / 18 / 4 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -112.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +97.2% |
| Market cap (USD) | $20.7M |